Arca
Skip to content
Tools
Tools

Gouty arthritis

Drug research and approvals for gouty arthritis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 12 studies of gouty arthritis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 3 authorised medicines for it.

  • Recruiting worldwide: 12
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 3

Recruiting now

Newest posted first, of 12 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 8

How its trials ended

50 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 7 whose ending is known, 0% met their primary endpoint, 14% missed it and 86% stopped early.

  • Completed, result not reported2142%
  • Ongoing1326%
  • Status unknown918%
  • Stopped: other or unclear48%
  • Missed its primary endpoint12%
  • Stopped: lack of efficacy12%
  • Stopped: enrollment or feasibility12%

Medicines authorised in the EU

Newest first

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.